Safety of SGLT2 Inhibitors in Kidney Transplant Recipients with Type 2 Diabetes Mellitus (T2DM) or New-Onset Diabetes after Transplant (NODAT): A Single-Centre Experience

Authors: Wigdan Hamza, Komal Moqeem, Aisha Riaz, Natasha Aj Moore, Elham Asgari, Caroline Dudreuilh

Published: 2024-10-28

DOI: 10.1681/asn.2024htm43m12

Keywords: No keywords found.

Abstract:
No abstract found.

Source: